Capricor Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-16.8M | $-18.0M | $1.2M | $3.0M |
| FY2022 | $4.9M | $2.9M | $2.0M | $4.5M |
| FY2023 | $-25.6M | $-26.9M | $1.3M | $7.4M |
| FY2024 | $-40.0M | $-41.2M | $1.2M | $9.8M |
| FY2025 | $-69.8M | $-72.7M | $2.9M | — |